- Home
- FSEA vs ITRM Comparison
FSEA vs ITRM Comparison
Compare FSEA & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ITRM
- Stock Information
- Founded
- FSEA 1890
- ITRM 2015
- Country
- FSEA United States
- ITRM Ireland
- Employees
- FSEA N/A
- ITRM N/A
- Industry
- FSEA Savings Institutions
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- ITRM Health Care
- Exchange
- FSEA Nasdaq
- ITRM Nasdaq
- Market Cap
- FSEA 43.6M
- ITRM 49.5M
- IPO Year
- FSEA N/A
- ITRM 2018
- Fundamental
- Price
- FSEA $10.17
- ITRM $1.75
- Analyst Decision
- FSEA
- ITRM Strong Buy
- Analyst Count
- FSEA 0
- ITRM 1
- Target Price
- FSEA N/A
- ITRM $5.00
- AVG Volume (30 Days)
- FSEA 10.8K
- ITRM 1.6M
- Earning Date
- FSEA 11-08-2024
- ITRM 11-14-2024
- Dividend Yield
- FSEA N/A
- ITRM N/A
- EPS Growth
- FSEA N/A
- ITRM N/A
- EPS
- FSEA N/A
- ITRM N/A
- Revenue
- FSEA $11,390,000.00
- ITRM N/A
- Revenue This Year
- FSEA N/A
- ITRM N/A
- Revenue Next Year
- FSEA N/A
- ITRM N/A
- P/E Ratio
- FSEA N/A
- ITRM N/A
- Revenue Growth
- FSEA N/A
- ITRM N/A
- 52 Week Low
- FSEA $7.25
- ITRM $0.81
- 52 Week High
- FSEA $10.38
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- FSEA 81.07
- ITRM 45.98
- Support Level
- FSEA $9.25
- ITRM $1.78
- Resistance Level
- FSEA $10.38
- ITRM $1.95
- Average True Range (ATR)
- FSEA 0.25
- ITRM 0.30
- MACD
- FSEA 0.11
- ITRM -0.10
- Stochastic Oscillator
- FSEA 87.02
- ITRM 0.00
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.